Table 2.
Clinical characteristics of individual TN patients
| Sex | Age (years) | Side | Duration (years) | Pre-op VAS (mm) | Branch | NVC score | SX types |
# prev SX |
Medications | |
|---|---|---|---|---|---|---|---|---|---|---|
| Responders: | ||||||||||
| 1 | M | 57.5 | R | 6 | 66 | 3 | 2 | MVD | 0 | carbamazepine |
| 2 | M | 49.0 | R | 1 | 100 | 1/2/3 | 2 | BC | 3 | oxcarbazepine, baclofen |
| 3 | M | 45.1 | L | 9 | 98 | 1 | 2 | MVD | 0 | carbamazepine, pregabalin |
| 4 | F | 58.5 | R | 11 | 100 | 2/3 | 3 | MVD | 0 | carbamazepine |
| 5 | M | 63.9 | R | 8 | 82 | 1/2/3 | 2 | MVD | 0 | carbamazepine |
| 6 | M | 67.5 | R | 6 | 71 | 2/3 | 1 | BC | 1 | carbamazepine |
| 7 | F | 74.1 | L | 3 | 81 | 2 | 3 | MVD | 0 | oxcarbazepine, pregabalin |
| 8 | F | 65 | R | 1 | 93 | 3 | 1 | MVD | 0 | gabapentin |
| 9 | F | 60.3 | L | 6 | 36 | 2/3 | 3 | MVD | 1 | gabapentin, amitriptyline |
| 10 | F | 64.9 | L | 7 | 100 | 2/3 | 3 | MVD | 0 | carbamazepine, gabapentin |
| 11 | F | 60.4 | L | 7 | 86 | 2/3 | 2 | MVD | 0 | carbamazepine, oxcarbazepine |
| 12 | F | 60.4 | R | 15 | 80 | 2/3 | 0 | BC | 0 | carbamazepine |
| 13 | M | 41.8 | R | 2 | 89 | 1/2 | 2 | MVD | 0 | carbamazepine, gabapentin, topiramate |
| 14 | F | 68.5 | L | 1 | 100 | 3 | 1 | MVD | 0 | carbamazepine |
| 15 | M | 61.5 | R | 2.5 | 79 | 3 | 0 | MVD/IN | 0 | carbamazepine |
| 16 | M | 63.3 | R | 2.5 | 95 | 2/3 | 3 | MVD | 0 | oxcarbazepine, lamotrigine, gabapentin |
| 17 | M | 40.6 | R | 1 | 15 | 2/3 | 0 | BC | 0 | carbamazepine, baclofen, duloxetine, cannabis oil |
| Non-Responders: | ||||||||||
| 18 | F | 37.3 | L | 6 | 63 | 2/3 | 0 | MVD/IN | 0 | oxcarbazepine, baclofen |
| 19 | F | 48.9 | L | 8 | 2 | 1/2/3 | 2 | MVD | 0 | carbamazepine, gabapentin, baclofen |
| 20 | F | 56.2 | R | 13 | 60 | 1/2/3 | 2 | BC | 1 | carbamazepine, gabapentin, lamotrigine, baclofen, hydromorphone |
| 21 | F | 55.5 | R | 3 | 100 | 1/2/3 | 0 | BC | 0 | oxcarbazepine, gabapentin |
| 22 | F | 57.5 | R | 13 | 100 | 1/2/3 | 0 | BC | 2 | carbamazepine, gabapentin |
| 23 | F | 36.3 | R | 3 | 89 | 2/3 | 3 | MVD | 0 | carbamazepine, gabapentin, baclofen, amitriptyline, cannabis oil |
M male; F female; VAS visual analogue scale; Branch affected trigeminal nerve branches; NVC neurovascular compression; SX surgical treatment; MVD microvascular decompression; BC balloon compression rhizotomy; IN internal neurolysis